Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-21 4:09 pm Purchase | 2023-11-14 | 13D | Fortress Biotech, Inc. FBIO | WEISS MICHAEL S | 1,130,520 7.600% | 1,130,520 (New Position) | Filing History |
| 2023-11-21 4:08 pm Purchase | 2023-11-14 | 13D | Fortress Biotech, Inc. FBIO | ROSENWALD LINDSAY A MD | 2,597,440 17.500% | 2,597,440 (New Position) | Filing History |
| 2023-09-26 4:16 pm Purchase | 2023-09-25 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,444,239 11.300% | 80,906 (+3.42%) | Filing History |
| 2023-09-18 5:08 pm Purchase | 2023-09-08 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 13,987 12.100% | 13,987 (New Position) | Filing History |
| 2023-07-06 4:44 pm Purchase | 2023-06-30 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,363,333 13.600% | 81,406 (+3.57%) | Filing History |
| 2023-04-19 4:24 pm Purchase | 2023-03-31 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,281,927 17.500% | 78,214 (+3.55%) | Filing History |
| 2023-02-14 5:01 pm Sale | 2022-12-31 | 13G | Fortress Biotech, Inc. FBIO | Nantahala Capital Management, LLC | 531,204 7.300% | -74,530 (-12.30%) | Filing History |
| 2023-02-14 4:35 pm Purchase | 2023-02-10 | 13D | Fortress Biotech, Inc. FBIO | KATZ DARYL | 403,532 4.760% | 29,707 (+7.95%) | Filing History |
| 2023-02-09 11:19 am Sale | 2022-12-30 | 13G | Fortress Biotech, Inc. FBIO | The Vanguard Group | 340,294 4.700% | -39,058 (-10.30%) | Filing History |
| 2023-01-13 4:13 pm Purchase | 2023-01-06 | 13D | Mustang Bio, Inc. MBIO | Fortress Biotech Inc. FBIO | 30,507 20.700% | 30,507 (New Position) | Filing History |
| 2023-01-13 4:13 pm Purchase | 2023-01-05 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,203,713 19.300% | 2,203,713 (New Position) | Filing History |
| 2023-01-06 4:31 pm Purchase | 2022-12-31 | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 7,710 11.300% | 4,296 (+125.86%) | Filing History |
| 2022-08-17 4:01 pm Purchase | 2021-11-16 | 13G | Journey Medical Corporation DERM | Fortress Biotech Inc. FBIO | 10,010,467 56.900% | 10,010,467 (New Position) | Filing History |
| 2022-02-14 08:13 am Purchase | 2021-12-31 | 13G | Fortress Biotech, Inc. FBIO | Nantahala Capital Management, LLC | 605,734 9.600% | 27,006 (+4.67%) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Fortress Biotech, Inc. FBIO | The Vanguard Group | 379,352 5.710% | 379,352 (New Position) | Filing History |
| 2021-05-07 5:09 pm Purchase | 2021-04-30 | 13G | Fortress Biotech, Inc. FBIO | BlackRock Inc. BLK | 320,948 5.000% | 6,330 (+2.01%) | Filing History |